Valuation Alpa Laboratories Limited

Stocks

Delayed NSE India S.E. 02:04:34 2026-08-17 EDT			5-day change	1st Jan Change
64.55 ^INR	+0.44%		-5.03%	-16.91%

08-13	Alpa Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
07-22	Alpa Laboratories Ltd. Announces Cessation of Ms. Jyoti Jain as an Independent Director, Effective July 21, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2020	2021	2022	2023	2024	2025
Market Cap ¹	291.4	757.5	1,467	1,132	1,752	2,180
Change	-	159.93%	93.61%	-22.81%	54.74%	24.44%
Enterprise Value (EV) ¹	-147.2	334.5	822.3	346.6	875.6	1,053
Change	-	327.25%	145.84%	-57.85%	152.61%	20.26%
P/E	15.7x	10.5x	10.4x	9x	10.4x	11.2x
PBR	0.29x	0.7x	1.2x	0.84x	1.15x	1.27x
PEG	-	0x	0.1x	-0.8x	0.3x	0.7x
Capitalization / Revenue	0.34x	0.78x	1.19x	1.22x	1.61x	1.94x
EV / Revenue	-0.17x	0.34x	0.67x	0.37x	0.81x	0.94x
EV / EBITDA	-2.51x	3.87x	3.83x	4.28x	10.2x	22.4x
EV / EBIT	-3.12x	4.52x	4.16x	5.13x	13.2x	42.1x
EV / FCF	-1.07x	-2.57x	4.89x	5.29x	-15.6x	23.7x
FCF Yield	-93.6%	-38.9%	20.4%	18.9%	-6.4%	4.22%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	0.8809	3.444	6.697	5.98	7.973	9.269
Distribution rate	-	-	-	-	-	-
Net sales ¹	859.7	975.5	1,230	929.6	1,087	1,125
EBITDA ¹	58.54	86.33	214.4	80.91	86.13	47.03
EBIT ¹	47.12	74.04	197.8	67.62	66.58	25.01
Net income ¹	18.53	72.47	140.9	125.8	167.8	195
Net Debt ¹	-438.6	-423	-644.3	-785.4	-876.1	-1,127
Reference price ²	13.85	36.00	69.70	53.80	83.25	103.60
Nbr of stocks (in thousands)	21,041	21,041	21,041	21,041	21,041	21,041
Announcement Date	9/5/20	9/6/21	9/3/22	9/5/23	9/4/24	9/4/25

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ALPA LABORATORIES LIMITED	-	-	-	-	14.14M
SUN PHARMACEUTICAL INDUSTRIES LTD.	35.61x	6.69x	23.16x	0.89%	48.43B
OTSUKA HOLDINGS CO., LTD.	18.56x	2.2x	10x	1.37%	39.72B
CIPLA LIMITED	28.23x	3.44x	17.81x	0.9%	12.25B
ZYDUS LIFESCIENCES LIMITED	27.22x	3.89x	16.12x	0.59%	11.84B
KRKA, D. D.	18.63x	3.31x	11.51x	3.87%	9.06B
GEDEON RICHTER	9.11x	2.11x	5.48x	4.42%	7.57B
ONO PHARMACEUTICAL CO., LTD.	15.83x	2.06x	6.7x	3.22%	7.18B
GLENMARK PHARMACEUTICALS LIMITED	35.19x	4.02x	17.09x	0.23%	6.84B
Average	23.55x	3.46x	13.48x	1.94%	15.88B
Weighted average by Cap.	26.05x	4.11x	15.67x	1.46%